SeqLL Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Billerica, mass., oct. 30, 2023 (globe newswire) -- seqll inc. (“seqll” or the “company”) (nasdaq: sql, sqllw), today announced the decision of its board of directors to cancel the special cash dividend and stock dividend that it intended to make to its common stockholders in connection with, and subject to, the consummation of its planned acquisition of lyneer investments llc (“lyneer”) and the disposition of its current business operations.

Billerica, mass., sept. 15, 2023 (globe newswire) -- seqll inc. (“seqll” or the “company”) (nasdaq: sql, sqllw), announced today that its board of directors has set september 26, 2023 as the record date for its special stock dividend and cash dividend to be made to the holders of its common stock pursuant to the terms of the agreement and plan of reorganization dated as of may 29, 2023, as amended (the “merger agreement”), by and among the company, seqll merger llc, atlantic acquisition corp., atlantic merger llc, lyneer investments, llc, idc technologies, inc. and lyneer management holdings llc. the dividend distribution of shares of common stock of the company and the cash dividend will be made to all seqll common stockholders of record as of the close of business on september 26, 2023 (the "record date")...

Billerica, mass., aug. 30, 2023 (globe newswire) -- seqll inc. (“seqll” or the “company”) (nasdaq: sql, sqllw), a technology company providing life sciences instrumentation and research services, today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-40. the reverse stock split will become effective at 11:59 p.m. eastern time, on august 30, 2023. the company's common stock will begin trading on a post-split basis at the market open on august 31, 2023, under the company's existing trading symbol "sql". the reverse stock split is part of the company's plan to regain compliance with the minimum bid price requirement of $1...

Billerica, mass., sept. 06, 2022 (globe newswire) -- seqll inc. (“seqll” or the “company”) (nasdaq: sql; sqllw), a technology company providing life sciences instrumentation and research services for collaborative partnerships, today announced that daniel jones, ceo of seqll will present a corporate overview and be available for virtual 1x1 meetings at the upcoming h.c. wainwright 24th annual global conference taking place from september 12-14, 2022.

Woburn, mass., sept. 29, 2021 (globe newswire) -- seqll inc. (“seqll” or the “company”) (nasdaq:sql; sqllw), a development-stage life sciences instrumentation and research services company engaged in the development of scientific assets and novel intellectual property across multiple “omics” fields, today announced the closing of the sale of an additional 189,000 shares of common stock at the initial public offering price of $4.24 per share, pursuant to the partial exercise of the underwriters' over-allotment option, in connection with its initial public offering that closed on august 31, 2021, resulting in gross proceeds of approximately $801,360. after giving effect to the exercise of the over-allotment option, the total gross proceeds of the initial public offering increased to approximately $13,810,950.

SeqLL (NASDAQ: SQL ) stock is on the rise Monday with heavy trading despite a lack of news from the molecule sequencing technology company. Getting into that trading, some 1.7 million shares of SQL stock have changed hands as of this writing.

Shares of SeqLL Inc. SQL, -38.69% more than doubled on heavy volume ahead of Friday's open, in the wake of the genetic sequencing company's announcement earlier in the week about an product development agreement with the Federal Bureau of Investigation. The stock skyrocketed 128.6% on volume of 16.1 million shares premarket, enough to make it the biggest gainer and most active stock listed on major U.S. exchanges.

SeqLL (NASDAQ: SQL ) stock is taking off on Friday morning despite a lack of news from the forensic company. Instead, it looks like traders can thank heavy trading for the boost to SQL's stock price this morning.

SeqLL (NASDAQ: SQL ) stock is seeing massive gains on Tuesday after signing a new contract with a government agency. Specifically, the company has signed a two-year Cooperative Research and Development Agreement (CRADA) with the Federal Bureau of Investigation (FBI).

Penny stocks to watch with news this month. The post 7 Penny Stocks To Watch With Big News In February; Time To Buy?

BILLERICA, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services for collaborative partnerships, today announced that Daniel Jones, CEO of SeqLL will present a corporate overview and be available for virtual 1x1 meetings at the upcoming H.C. Wainwright 24th Annual Global Conference taking place from September 12-14, 2022.

A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It's a measure put in place to help restore and bring order to the markets.

WOBURN, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:SQL; SQLLW), a development-stage life sciences instrumentation and research services company engaged in the development of scientific assets and novel intellectual property across multiple “omics” fields, today announced the closing of the sale of an additional 189,000 shares of common stock at the initial public offering price of $4.24 per share, pursuant to the partial exercise of the underwriters' over-allotment option, in connection with its initial public offering that closed on August 31, 2021, resulting in gross proceeds of approximately $801,360. After giving effect to the exercise of the over-allotment option, the total gross proceeds of the initial public offering increased to approximately $13,810,950.

Method developed by leading researchers at the Bernstein Laboratory and SeqLL Inc.

This sector is always a risky area to gamble in. If you have the stomach for it, however, these biotech stocks could see massive gains.